tradingkey.logo

Avalon Globocare Corp

ALBT
1.960USD
-0.130-6.22%
終値 11/04, 16:00ET15分遅れの株価
4.60M時価総額
損失額直近12ヶ月PER

Avalon Globocare Corp

1.960
-0.130-6.22%

詳細情報 Avalon Globocare Corp 企業名

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering transformative, precision diagnostics and clinical laboratory services. The Company offers diagnostic testing utilizing proprietary technology to deliver genetics-driven results. It operates through two segments: Real property rental and Lab Services MSO. Lab Services MSO segment is focused on delivering services related to toxicology and wellness testing and provides a portfolio of diagnostic tests including drug testing, toxicology, and a range of test services, from general bloodwork to anatomic pathology, and urine toxicology. Its capabilities include STAT blood testing, qualitative drug screening, genetic testing, urinary testing, and sexually transmitted disease testing. The Lab Services MSO segment is also focused on the commercialization of genetic-based proprietary testing. It is also exploring the commercialization and development of a versatile breathalyzer system, KetoAir breathalyzer.

Avalon Globocare Corpの企業情報

企業コードALBT
会社名Avalon Globocare Corp
上場日Feb 22, 2016
最高経営責任者「CEO」Dr. David Jin, M.D., Ph.D.
従業員数5
証券種類Ordinary Share
決算期末Feb 22
本社所在地4400 Route 9
都市FREEHOLD
証券取引所NASDAQ Capital Market Consolidated
United States of America
郵便番号07728
電話番号17327804400
ウェブサイトhttps://www.avalon-globocare.com/
企業コードALBT
上場日Feb 22, 2016
最高経営責任者「CEO」Dr. David Jin, M.D., Ph.D.

Avalon Globocare Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Company Secretary
Chief Operating Officer, Company Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Wilbert J. (Billy) Tauzin, II
Mr. Wilbert J. (Billy) Tauzin, II
Director
Director
--
--
Dr. The Hon. Tevi Troy, Ph.D.
Dr. The Hon. Tevi Troy, Ph.D.
Independent Director
Independent Director
--
--
Mr. William B. Stilley, III
Mr. William B. Stilley, III
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Wenzhao (Daniel) Lu
Mr. Wenzhao (Daniel) Lu
Chairman of the Board of Directors
Chairman of the Board of Directors
238.93K
--
Dr. David Jin, M.D., Ph.D.
Dr. David Jin, M.D., Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
103.00K
--
Ms. Meng Li
Ms. Meng Li
Chief Operating Officer, Company Secretary
Chief Operating Officer, Company Secretary
34.33K
--
Mr. Steven Andrew Sanders, J.D.
Mr. Steven Andrew Sanders, J.D.
Independent Director
Independent Director
--
--
Ms. Lourdes Felix
Ms. Lourdes Felix
Independent Director
Independent Director
--
--
Ms. Luisa Ingargiola
Ms. Luisa Ingargiola
Chief Financial Officer
Chief Financial Officer
--
--

収益内訳

データなし
データなし
事業別
地域別
データなし

株主

更新時刻: Wed, Sep 3
更新時刻: Wed, Sep 3
株主統計
種類
株主統計
株主統計
比率
Lu (Wenzhao)
6.23%
Jin (David)
2.69%
Vision Capital NY, Inc.
2.61%
Li (Meng)
0.90%
Geode Capital Management, L.L.C.
0.54%
他の
87.05%
株主統計
株主統計
比率
Lu (Wenzhao)
6.23%
Jin (David)
2.69%
Vision Capital NY, Inc.
2.61%
Li (Meng)
0.90%
Geode Capital Management, L.L.C.
0.54%
他の
87.05%
種類
株主統計
比率
Individual Investor
9.84%
Corporation
2.61%
Investment Advisor
0.66%
Investment Advisor/Hedge Fund
0.54%
Research Firm
0.03%
他の
86.33%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
31
47.28K
1.23%
-3.08K
2025Q2
37
494.33K
14.25%
+85.10K
2025Q1
39
494.33K
24.18%
+84.18K
2024Q4
39
426.83K
39.01%
+28.37K
2024Q3
38
465.14K
44.22%
+32.28K
2024Q2
37
431.58K
58.50%
+7.86K
2024Q1
35
421.26K
56.90%
-5.41K
2023Q4
36
425.06K
58.60%
-685.00
2023Q3
43
423.55K
58.41%
-5.26K
2023Q2
52
423.10K
61.82%
-6.80K
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
Lu (Wenzhao)
238.93K
6.23%
+9.00
+0.00%
Mar 31, 2025
Jin (David)
103.00K
2.69%
--
--
Mar 31, 2025
Vision Capital NY, Inc.
100.00K
2.61%
+100.00K
--
Mar 31, 2025
Li (Meng)
34.33K
0.9%
+1.00
+0.00%
Mar 31, 2025
Geode Capital Management, L.L.C.
9.34K
0.24%
--
--
Aug 31, 2025
Equitable Holdings, Inc.
14.22K
0.37%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
1.58K
0.04%
--
--
Aug 31, 2025
UBS Financial Services, Inc.
4.20K
0.11%
+1.64K
+64.05%
Jun 30, 2025
Tauzin (Wilbert J II)
1.04K
0.03%
+1.04K
--
Mar 31, 2025
Citi Investment Research (US)
951.00
0.02%
+951.00
--
Jun 30, 2025
詳細を見る

関連ETF

銘柄名
比率
データなし

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
日付
種類
比率
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Oct 24, 2024
Merger
15→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
Jan 04, 2023
Merger
10→1
KeyAI